Robert S. Laitman, MD, discusses evidence supporting the reclassification of schizophrenia as a neurological disorder, his views on how reclassification could impact prognosis and recovery, and treatment interventions he says have led to meaningful recovery in his patients with schizophrenia. For more, visit www.consultant360.com.

Angela Fitch, MD, from Massachusetts General Hospital, discusses evidence-based management of obesity in primary care, including nutrition and physical activity interventions, and the pillars of treatment. For more, visit www.consultant360.com.

In this podcast, Harold Bays, MD, gives an overview of his session at our upcoming Cardiometabolic Risk Summit, which includes a discussion about non-alcoholic fatty liver disease, how fat affects the liver, and why patients (and cardiologists) should worry about this disease. More at: www.consultant360.com/cardiology.

In this podcast, Donna Ryan, MD, MABOM, talks about evaluating obesity medications, her tips for choosing the right medication for the right patient, and medications that are on the horizon. This is also the topic of her session at our Cardiometabolic Risk Summit 2019 in October. More at: www.consultant360.com/cardiology.

Stephen Harrison, MD, from Pinnacle Clinical Research, discusses the prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the United States, the correlation between NAFLD and obesity, and more.

More at: www.consultant360.com/gastroenterology.

In this podcast, David G. Hill, MD, talks about the top questions about idiopathic pulmonary fibrosis (IPF) that he receives from his colleagues in primary care, how to answer them, and everything else you need to know about IPF. More at: www.consultant360.com/pulmonology.

In this podcast, Meredith Duncan, from Vanderbilt University, discusses her latest research on how smoking cessation affects cardiovascular disease risk. More at: www.consultant360.com/cardiology.

Girish Melkani, MS, PhD, talks about how time-restricted eating affects circadian rhythm and metabolic function. He says when you eat is just as important as what you eat. More at: www.consultant360.com/cardiology.

In this podcast, Jacob Sands, MD, discusses lung cancer stigma, how it affects patient outcomes, and how providers can overcome the stigma. More at: www.consultant360.com/pulmonology.

Jenna Marcus, MD, from Rutgers New Jersey Medical School, discusses ovarian cancer risk stratification, screening and prophylactic strategies among populations with elevated ovarian cancer risk, and current screening guidelines. For more, visit www.consultant360.com.